The AI Utopia Doesn't Exist Without Bio
https://nfx.com/post/ai-and-bio-future-
AI leaders (Altman, Hassabis, Huang) all frame AI’s peak promise as bio.
- Disease curing, longevity, scientific discovery = their go-to examples.
- Bio is where AI makes its greatest impact, not consumer chat.
-
NFX portfolio: Mana Bio (LNP design), Zip Bio (protein LMs), La Jolla Labs (RNA drugs).
- Pumpkinseed: spectroscopy chips generating proprietary bio data.
-
Bio founders underestimate access to tech capital by ignoring AI framing.
- Tech investors grok data moats, defensibility, platform scaling.
-
Non-AI bio companies can reframe as translation layers between prediction and wet lab.
- Or: AI for regulatory risk mitigation as the pitch angle.
- Scientists alone can direct AI at humanity’s hardest problems.
X discourse
- @BoWang87: “AI × bio: too slow for AI people, too fast for bio people” (786 likes)
- @bravo_abad: “LLMs don’t understand chemistry — they just need the right representation” (273 likes)
- @oprydai: “AI without neuroscience is blind pattern fitting” (206 likes)
- @Oliver__Hahn: “Computational biology quietly doing more than AI hypothesis headlines” (88 likes)
Omri Drory, Ph.D. — General Partner, NFX · 2025-09-24 · Read on nfx.com
| Type | Link |
| Added | Sep 24, 2025 |
| Modified | Apr 17, 2026 |